Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY 4.0Emerging Microbes & Infections

Worldwide emergence of SARS-CoV-2 NB.1.8.1 sublineage with spike 420N and 478T dual substitution

5 affiliations
  1. 1State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, School of Clinical Medicine, the University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China
  2. 2Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Shatin, Hong Kong Special Administrative Region, People’s Republic of China
  3. 3Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China
  4. 4Pandemic Research Alliance Unit at the University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China
  5. 5Department of Infectious Disease and Microbiology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People’s Republic of China

Abstract

Background: After a year of quiescence, SARS-CoV-2 activity increased rapidly in Hong Kong since June 2026. We sought to characterize the genomic profile of SARS-CoV-2 driving this COVID-19 surge in Hong Kong and to examine the global dissemination of the identified circulating lineages.

Methods: We performed SARS-CoV-2 whole-genome sequencing on archived respiratory specimens collected at Queen Mary Hospital, Hong Kong, between January 2025 and July 2026. Viral lineages were assigned via Nextclade. Global SARS-CoV-2 metadata downloaded from GISAID as of July 2026 were analysed to track global evolutionary trends.

Results: Among 615 successfully sequenced strains, the XDV descendant NB.1.8.1 was the predominant lineage. Between April and July 2026, NB.1.8.1 descendants accounted for 95.6% (108/113) of sequenced strains, dominated by PQ.16.1.1 (81.5%). Spike substitutions 420N and 478T emerged rapidly. While 478T increased gradually throughout 2025, 420N emerged in April 2026 and reached 98.0% by June–July 2026. Strains harbouring 420N-478T dual substitution arose independently across distinct NB.1.8.1 lineages, accounting for 94.4% (102/108) of NB.1.8.1 descendants in Hong Kong during this period. Globally, the prevalence of NB.1.8.1 strains with 420N-478T dual substitution increased from <1% before April 2026 to 50.7% by mid-July 2026, with the highest prevalence observed in Southeast Asia and Australia.

Conclusion: The 2026 COVID-19 surge in Hong Kong was driven by NB.1.8.1 descendants harbouring spike 420N and 478T substitutions. The rapid worldwide expansion of these dual-substitution lineages highlights their competitive growth advantage and underscores the need for continued global genomic surveillance.

Related

  1. N-Glycosylation in the Receptor Binding Domain serves as aggregation gatekeeper of the SARS CoV2 Spike glycoprotein folding
    Anita Kumari, Beena Krishnan
    Journal of Biological ChemistryPeer-reviewedCC BY-NC-ND 4.0Infectious diseaseCrossref
  2. The Relationship among SARS-CoV-2, Vaccine Spike Protein, Renin- Angiotensin System, and Epilepsy
    Ziad Fajloun, Layla Tajer, Hervé Kovacic +1
    Infectious Disorders - Drug TargetsPeer-reviewedCC BY 4.0Full textInfectious diseaseHAL
  3. Supramolecular assembly and membrane anchoring alter variant-induced SARS-CoV-2 Spike conformational dynamics
    Amanda J. Gramm, Sean M. Braet, Bindu Y. Srinivasu +7
    Biophysical journalPeer-reviewedLicence not statedFull textInfectious diseasePMC
  4. Lipidated macrocyclic peptide S-880008 inhibits SARS-CoV-2 fusion by suppressing protomer dissociation at conserved spike sites
    Takao Sanaki, Yoshimasa Kawaguchi, Yuki Anraku +22
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Infectious diseaseCrossref
  5. Sex, age and HIV-1 status influence complement activation against SARS-CoV-2 mRNA vaccine Spike protein
    D. J. Tuttle, P. Tien, N. P. Sluis-Cremer +3
    medRxivPreprintCC BY-NC-NDFull textInfectious diseasemedRxiv
BibTeX
@article{tsoi2026worldwide,
  title = {{Worldwide emergence of SARS-CoV-2 NB.1.8.1 sublineage with spike 420N and 478T dual substitution}},
  author = {Hoi-Wah Tsoi and Wan-Mui Chan and Allen Wing-Ho Chu and Cassie Yu-Sen Yip and Xiaojuan Zhang and Jonathan Daniel Ip and Yanling Luo and Hin Chu and Kwok-Yung Yuen and Kelvin Kai-Wang To},
  journal = {Emerging Microbes \& Infections},
  year = {2026},
  month = oct,
  doi = {10.1080/22221751.2026.2755643},
  url = {https://doi.org/10.1080/22221751.2026.2755643},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Worldwide emergence of SARS-CoV-2 NB.1.8.1 sublineage with spike 420N and 478T dual substitution
AU  - Hoi-Wah Tsoi
AU  - Wan-Mui Chan
AU  - Allen Wing-Ho Chu
AU  - Cassie Yu-Sen Yip
AU  - Xiaojuan Zhang
AU  - Jonathan Daniel Ip
AU  - Yanling Luo
AU  - Hin Chu
AU  - Kwok-Yung Yuen
AU  - Kelvin Kai-Wang To
PY  - 2026
DA  - 2026/10/26
JO  - Emerging Microbes & Infections
DO  - 10.1080/22221751.2026.2755643
UR  - https://doi.org/10.1080/22221751.2026.2755643
AB  - Background: After a year of quiescence, SARS-CoV-2 activity increased rapidly in Hong Kong since June 2026. We sought to characterize the genomic profile of SARS-CoV-2 driving this COVID-19 surge in Hong Kong and to examine the global dissemination of the identified circulating lineages.  Methods: We performed SARS-CoV-2 whole-genome sequencing on archived respiratory specimens collected at Queen Mary Hospital, Hong Kong, between January 2025 and July 2026. Viral lineages were assigned via Nextclade. Global SARS-CoV-2 metadata downloaded from GISAID as of July 2026 were analysed to track global evolutionary trends.  Results: Among 615 successfully sequenced strains, the XDV descendant NB.1.8.1 was the predominant lineage. Between April and July 2026, NB.1.8.1 descendants accounted for 95.6% (108/113) of sequenced strains, dominated by PQ.16.1.1 (81.5%). Spike substitutions 420N and 478T emerged rapidly. While 478T increased gradually throughout 2025, 420N emerged in April 2026 and reached 98.0% by June–July 2026. Strains harbouring 420N-478T dual substitution arose independently across distinct NB.1.8.1 lineages, accounting for 94.4% (102/108) of NB.1.8.1 descendants in Hong Kong during this period. Globally, the prevalence of NB.1.8.1 strains with 420N-478T dual substitution increased from <1% before April 2026 to 50.7% by mid-July 2026, with the highest prevalence observed in Southeast Asia and Australia.  Conclusion: The 2026 COVID-19 surge in Hong Kong was driven by NB.1.8.1 descendants harbouring spike 420N and 478T substitutions. The rapid worldwide expansion of these dual-substitution lineages highlights their competitive growth advantage and underscores the need for continued global genomic surveillance.
SN  - 2222-1751
ER  -